Journals / Retina-Vitreus / 2001 / Cilt: 9 - Sayı: 3

High-dose corticosteroid treatment in traumatic optic neuropathy

Travmatik optik nöropatide yüksek doz kortikosteroid tedavisi

Pages
240–247
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Corticosteroid therapy may not be helpful in eyes with TON with delayed treatment or without light perception at the time of diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Methods: The medical records of 9 patients (8 male, 1 female; age range, 4-69 years) who received high dose-corticosteroid treatment because of indirect TON, between January 1998 and May 2001, were reviewed.
📊
Key Findings & Data:Optic neuropathy had developed as a result of traffic accident in 4 patients, falling from height in 3 patients, occupational injury in 1 patient, and firearm injury in 1 patient.
💡
Conclusion & Impact:Corticosteroid therapy may not be helpful in eyes with TON with delayed treatment or without light perception at the time of diagnosis.
🔬Design:Review & Systematic Survey
📍Scope:2001 Verileri
⚙️Variables:Yaralar ve yaralanmalar · Görme keskinliği · Geriyedönük çalışma

Abstract

Methods: The medical records of 9 patients (8 male, 1 female; age range, 4-69 years) who received high dose-corticosteroid treatment because of indirect TON, between January 1998 and May 2001, were reviewed. Optic neuropathy had developed as a result of traffic accident in 4 patients, falling from height in 3 patients, occupational injury in 1 patient, and firearm injury in 1 patient. Three patients had bilateral TON. At the time of diagnosis, the visual acuity ranged from 0.4 to hand movements in 9 eyes and 3 eyes had no light perception. Five patients received very-high-dose intravenous methylprednisolone treatment (2000-5000 mg/day), and 4 received high-dose treatment (1000 mg/day). The median duration between the visual loss and initiation of the treatment was 7 days (range: 1-60 days). The mean follow-up time was 4.5 months (range: 1-10 months). Results: After treatment, the visual acuity improved in 8 of 12 eyes (67%) and remained unchanged in 4 eyes (33%). The light perception was negative at the time of diagnosis in 3 of the 4 eyes without visual improvement. The median time between the trauma and the initiation of the treatment was 5.5 days (range: 1-21 days) in the group of patients whose vision improved and 14 days in the group of patients whose vision did not change. No serious complication due to treatment developed in any patient. Discussion: Superiority of either surgical or medical treatment methods over each other in indirect TON is controversial. In this limited study, high-dose intravenous methylprednisolone treatment yielded highly successful results. Corticosteroid therapy may not be helpful in eyes with TON with delayed treatment or without light perception at the time of diagnosis.

Özet

Amaç: Travmatik optik nöropatide (TON) yüksek doz intravenöz kortikosteroid tedavisinin etkinliğini değerlendirmek. Yöntem: Ocak 1998-Mayıs 2001 arasında indirekt TON nedeniyle yüksek doz kortikosteroid tedavisi uygulanan 9 hastanın (8 erkek, 1 kadın; yaş aralığı, 4-69 yıl) dosyası gözden geçirildi. Optik nöropati 4 hastada trafik kazası, 3 hastada yüksekten düşme, 1 hastada iş kazası ve 1 hastada ateşli silah yaralanması sonucunda gelişmişti. Üç hastada TON bilateraldi (toplam 12 göz). Tanı sırasında görme keskinliği 9 gözde el hareketleri ile 0.4 arasında değişiyordu; 3 gözde ışık hissi negatifti. Beş hastaya çok yüksek dozda (2000-5000 mg/gün), 4 hastaya yüksek dozda (1000 mg/gün) intravenöz metilprednizolon tedavisi uygulandı. Tedavinin başlaması ile görme kaybı arasındaki süre, ortanca değer olarak 7 gündü (değer aralığı: 1-60 gün). Ortalama izlem süresi 4.5 aydı (değer aralığı: 1-10 ay). Bulgular: Tedaviden sonra, 12 gözden 8'inde (%67) görme keskinliği arttı, 4 gözde (%33) ise aynı kaldı. Görsel iyileşme olmayan 4 gözden 3'ünde, tanı sırasında ışık hissi negatifti. Travma ile tedavinin başlangıcı arasındaki ortanca süre, görme artışı olan hasta grubunda 55 gün (1-21 gün), görmenin aynı kaldığı grupta ise 14 gündü (4-60 gün). Hiçbir hastada tedaviye bağlı ciddi bir komplikasyon gelişmedi. Tartışma: İndirekt TON'de cerrahi ve medikal tedavi yöntemlerinin birbirine üstünlüğü tartışmalıdır. Bu sınırlı çalışmada, yüksek doz intravenöz metilprednizolon tedavisi oldukça başarılı sonuçlar sağladı. Kortikosteroid tedavisi tanı sırasında ışık hissi olmayan ve tedavinin geciktiği TON'li gözlerde yararlı olmayabilir.

🔖

Cite This Article

YAZICI, B., YILDIZ, M., GELİŞKEN, Ö. (2001). High-dose corticosteroid treatment in traumatic optic neuropathy. Retina-Vitreus, Cilt: 9 - Sayı: 3, 240–247. https://ajindex.com/articles/305398

References (18)

  1. Kline LB, Morawetz RB, Swaid SN. Indirect injury of the optic nerve. J Neurosurg 1984, 14:756-64
  2. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy. Surv Ophthalmol. 1994, 38:487-518
  3. Joseph MP, Lessell S, Rizzo J et al. Extracranial optic nerve decompression for traumatic optic neuropathy. Arch Ophthalmol 1990, 108:1091-3
  4. Lessell S. Indirect optic nerve trauma. Arch Ophthalmol 1989, 107:382-6
  5. Cook MW, Levin LA, Joseph MP et al. Traumatic optic neuropathy. A meta-analysis. Arch Otolaryngol Head Neck Surg 1996, 122:389-92
  6. Spoor TC, Hartel WC, Lensink DB et al. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol 1990, 110:665-9
  7. Levin LA, Beck RW, Joseph MP et al. The treatment of traumatic optic neuropathy: The International Optic Nerve Trauma Study. Ophthalmology 1999, 106:1268-77
  8. Anderson RL, Panje WR, Gross CE. Optic nerve blindness following blunt forehead trauma. Ophthalmology 1982, 89:445-55
  9. Kennerdel JS, Amsbaugh GA, Myers EN. Tran-santral-etmoidal decompression of optic canal fracture. Arch Ophthalmol 1976, 94:1040-3
  10. Anderson DK, Means ED, Waters TR et al. Mic-rovascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg 1982,56:106-13
  11. Hall ED. High dose glucocorticoid treatment improves neurogical recovery in head-injured mice. J Neurosurg 1985,62:882-7
  12. Bracken MB, Shepard MJ, Collins WF et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the second national acute spinal cord injury study. N Engl J Med 1990, 322:1405-11
  13. Bracken MB, Shepard MJ, Holford TR et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997,277:1597-1604
  14. Hall ED, Braughler JM. Glucocorticoid mechanism in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982, 18:320-7
  15. Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992, 76:13-22
  16. Fujitani T, Inoue K, Takahashi T et al. Indirect traumatic optic neuropathy-visual outcome of operative and nonoperative cases. Jpn J Ophthalmol 1986, 30:125-34
  17. Chou PI, Sadun AA, Chen YC et al. Clinical experiences in the management of traumatic optic neuropathy. Neuro-ophthalmology 1996, 16:325-6
  18. Seiff SR. High dose corticosteroids for treatment of vision loss due to indirect in